Paul Hastings advised the underwriters on the offering. Clifford Chance acted for Unisound AI. Unisound AI Technology Co., Ltd. has successfully completed a global offering and...
Unisound Completes HK$320 Million Global IPO and Listing on Hong Kong Stock Exchange
Black Sesame International Holding’s $133 Million IPO on HKSE
Clifford Chance advised Black Sesame International Holding on the deal. Black Sesame International Holding, a chip designer for autonomous vehicles, has raised $133 million from an...
RoboSense Technology’s IPO and Listing on Hong Kong Stock Exchange
Clifford Chance advised RoboSense Technology Co., Ltd. Light Detection and Ranging (LiDAR) and perception solutions company RoboSense Technology Co., Ltd completed its initial public offering and listing...
Kanzhun Limited’s Dual Primary Listing
Maples and Calder, together with Skadden, acted for Kanzhun Limited. Clifford Chance advised Morgan Stanley and Goldman Sachs. Morgan Stanley and Goldman Sachs agreed for dual...
OneConnect’s Dual Primary Listing By Way of Introduction
Maples Group acted as Cayman Islands legal counsel, Cleary Gottlieb Steen & Hamilton acted as legal advisors to OCFT as to Hong Kong and US laws...
Recbio Technology Co., Ltd.’s US$98 Million Initial Public Offering
Kirkland & Ellis advised Jiangsu Recbio Technology Co., Ltd., while Clifford Chance has advised the joint sponsors and underwriters involved in the deal. Recbio Technology Co.,...
MicroTech Medical’s US$249 Million Initial Public Offering
Davis Polk advised MicroTech Medical, while Clifford Chance has advised the joint sponsors involved in the transaction. The Hangzhou-based firm offers diabetes therapy and manufactures medical...
Dongguan Rural Commercial Bank’s US$1.2 Billion Hong Kong IPO
King & Wood Mallesons (KWM) advised Dongguan Rural Commercial Bank Co., Ltd., while Clifford Chance has advised the joint sponsors. Dongguan Rural Commercial Bank Co., Ltd....
Bilibili Inc.’s $2.6 Billion Secondary Listing
Walkers acted as Cayman Islands counsel to Bilibili Inc. in connection with its US$2.6 billion global offering of 25 million shares on the Main Board of...
SciClone Pharmaceuticals’ Hong Kong Initial Public Offering And Listing
Clifford Chance, Maples and Calder JunHe advised SciClone Pharmaceuticals on its US$281 million initial public offering and listing on the main board of the Hong Kong...
JD.com’s US$3.87 Billion Hong Kong IPO And Secondary Listing
Clifford Chance has advised the joint sponsors Bank of America, UBS and CLSA, and the underwriters on JD.com’s US$3.87 billion initial public offeringand secondary listing on...